Community-based Management of Chronic Obstructive Pulmonary Disease in Nepal

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1438 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-25

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease (COPD) is the fourth most important cause of death worldwide and is one of the commonest non-communicable diseases (NCDs) in Nepal. The presence of risk factors like indoor and outdoor air pollution, the high prevalence of smoking and lack of general awareness of COPD makes it a serious public health concern. However, no attempt has been made in Nepal to estimate its burden and address the disease at the community level. This community-based cluster randomized controlled study aims to fulfil that gap through mobilization of Female Community Health Workers (FCHVs) who will be trained to perform a certain set of health promotion activities aimed at prevention of the disease and its progression. Baseline and follow-up surveys will be conducted to compare the intervention and control groups. This study has the potential to generate evidence in helping address NCDs in Nepal and also other similar resource-limited countries.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00702078

COPD

COMPLETED NA

Digital Follow-up Program for People with Chronic Obstructive Pulmonary Disease in Primary Healthcare

NCT06401512

COPD Chronic Obstructive Pulmonary Disease

RECRUITING NA

Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease

NCT00317057

Chronic Obstructive Pulmonary Disease

UNKNOWN NA

Effects of an Active Implementation of a Guideline for Chronic Obstructive Pulmonary Disease

NCT01228708

Implementation of a Chronic Disease Management Programme COPD

COMPLETED NA

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

NCT00705302

Chronic Obstructive Pulmonary Disease (COPD)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Group Type EXPERIMENTAL

Behavioural-FCHV Visit

Intervention Type BEHAVIORAL

Female Community Health Volunteer will visit selected households on average 3 times a year for providing health promotion messages on improving lung health status and avoiding risk factors to COPD.

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioural-FCHV Visit

Female Community Health Volunteer will visit selected households on average 3 times a year for providing health promotion messages on improving lung health status and avoiding risk factors to COPD.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Capable of performing spirometry
* Aged greater than and equal to 40 years
* Full time residents in the study area and will be in the study area for at least one year

Exclusion Criteria

* Younger than 40 years of age
* Self-reported pregnancy
* having active pulmonary tuberculosis or being on medications for pulmonary tuberculosis
* thoracic, abdominal or eye surgery in the last six months
* History of Mental illness
* MI in past 8 weeks prior to study
* Hospital admission in the past six months for cardiac illness
* Those who decline to provide consent to the study will be excluded.

Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes